▚ peptidetrust
home / Guides / What a Tirzepatide Certificate of Analysis Must Show
guide

What a Tirzepatide Certificate of Analysis Must Show

A field by field look at the identity, purity, quantity and traceability evidence a batch-level tirzepatide CoA should contain, and how to spot one that was reused.

By Marcus Vela · 2026-11-19 · 7 min read

What a Tirzepatide Certificate of Analysis Must Show
Photo: Antoni Shkraba / Pexels

A certificate of analysis (CoA) for tirzepatide is a laboratory document recording what a named lab measured in one specific batch of material: its identity, its chromatographic purity, and sometimes the quantity of peptide in each vial. It is a factual record of composition at a point in time, not a quality promise and not a statement about use. Material supplied with these documents is sold for research use only. This guide explains, field by field, which evidence a credible tirzepatide CoA must contain, and how to recognise a certificate that was written once and then reused across many batches.

What does a tirzepatide CoA actually certify?

A CoA answers a narrow question: what did a laboratory find when it analysed a sample drawn from one batch? For a synthetic peptide such as tirzepatide, that normally means two independent measurements. Mass spectrometry (MS) establishes identity, confirming the molecule has the mass expected for the sequence claimed. High-performance liquid chromatography (HPLC) establishes purity, reporting the target peak as a percentage of total peak area. Everything else on the page is traceability: who tested, which lot, on what date, by which method. A CoA does not certify sterility, it does not certify that material is safe, and it says nothing about what a compound does. Transparency is a documentary property, not a marketing claim, and a certificate is only as good as the evidence a reader can check independently. If the layout is unfamiliar, our guide on how to read a peptide CoA walks through each block in order.

Which test proves the vial contains tirzepatide and not another peptide?

Mass spectrometry. Identity and purity answer different questions, and this is the distinction most buyers miss. An HPLC trace can show a single sharp peak at 99 percent of total peak area and still describe the wrong molecule, because HPLC separates, it does not identify. MS measures molecular mass, so it is the test that rules out a substitution. On a tirzepatide CoA, look for an MS or LC-MS (liquid chromatography mass spectrometry) section that names the method, states the observed mass against the theoretical mass for the sequence claimed, and ideally reproduces the spectrum rather than a single line of text. A certificate carrying a purity figure with no identity data leaves the central question open. The two methods are compared in our guide on HPLC versus mass spectrometry for peptide testing.

What should the HPLC purity section show besides a percentage?

The chromatogram, not just a number. A printed value such as 99.1 percent is a conclusion; the plotted trace is the evidence behind it. A usable chromatogram shows the time axis and detector response, a stable baseline, the integrated main peak with its retention time, and any smaller impurity peaks with their individual areas. Method details belong beside it: column, mobile phase and gradient, detection wavelength, injection volume and run time. Those details let a reader judge whether the separation could resolve closely related impurities at all, or whether part of the run was simply cut off. Points to check:

  • Is the peak table consistent with the headline purity figure?
  • Does the trace carry the sample or lot identifier, or is it an unlabelled image?
  • Are the injection date and the instrument or operator recorded?
  • Is the full time range shown, including the solvent front region?

Why does quantity per vial matter on a tirzepatide CoA?

Because purity is a relative measure and fill mass is an absolute one. A percentage by area describes the composition of whatever was injected, so it cannot tell you how much peptide a vial holds. Underfilled vials are a recognised issue in this market, and only a quantification test addresses it: an HPLC assay against a reference standard reported as mass per vial, or amino acid analysis (AAA) reporting net peptide content. Net peptide content is a separate figure from chromatographic purity, because lyophilised material also contains water, salts and counter-ions such as trifluoroacetate (TFA) or acetate. A vial can therefore be high in purity and still contain less peptide than the label states. On the certificate, confirm that the quantification section names its method, states its units, and compares the measured value against the labelled content for that specific lot.

How do you check batch traceability on a tirzepatide CoA?

Start at the vial and work back to the laboratory. The lot or batch number printed on the label must appear on the certificate, character for character. From there, a traceable document names the laboratory that performed the work (an independent third-party lab such as Janoshik or MZ Biolabs, for example, rather than an unnamed lab described only by country), gives the date the sample was received and the date of analysis, and identifies the sample as submitted. Accreditation to ISO/IEC 17025, the international standard for the competence of testing laboratories, is a stronger signal than no accreditation. The strongest element of all is a verification mechanism: a code or QR link that resolves on the laboratory's own domain, so the result is verifiable at the source instead of existing only in a PDF hosted by the seller.

Does a tirzepatide CoA say anything about endotoxin or sterility?

Usually not, and that absence is normal. A standard identity and purity certificate reports chemistry, not microbiology. Endotoxins (bacterial lipopolysaccharides) are measured by the LAL (Limulus Amebocyte Lysate) assay and reported in endotoxin units per milligram or per millilitre, under the compendial chapter USP <85>. Sterility, meaning the absence of viable microorganisms, is a different test under USP <71>. Passing one does not imply the other, and a purity CoA implies neither. The practical rule concerns claims: where endotoxin or sterility testing is advertised, a matching report should exist for that exact lot, naming the method, the result with units, and the limit applied. A claim with no document behind it is unsupported. Equally, a silent certificate is not a sterility guarantee; it simply did not test for it.

How can you tell a CoA has been reused across batches?

A reused certificate is one document presented for material it never described. The signature is uniformity: the same file appears for several products or several restocks, with no lot number, or with a lot number that does not match the vial. Other signs include a date of analysis far older than the stock on sale, an identical purity figure repeated across unrelated items, a chromatogram with no sample identifier, and image artefacts that are identical across separate downloads. Compare the two documentary models:

ElementBatch-level CoAGeneric CoA
Lot numberPresent, matches the vialAbsent or left blank
Date of analysisSpecific, close to the production runOld, missing or reused
ChromatogramAttached and labelled with the sample IDMissing, cropped or unlabelled
LaboratoryNamed and verifiable at the sourceUnnamed or impossible to locate
ScopeOne batch at one point in timeThe product in general, indefinitely

Red flags that justify walking away:

  • CoAs released only by email after purchase.
  • A verification code, QR link or portal that leads nowhere.
  • A purity percentage with no chromatogram attached.
  • A laboratory name that cannot be shown to exist.

How does this checklist turn into a vendor score?

These checks are the basis of the PeptideTrust scorecard, which rates vendors on documentary transparency alone: whether batch-level certificates from named, independent laboratories are published openly and can be verified at the source. The scorecard does not assess products, and it makes no claim about what any compound does. Our methodology page sets out the ten weighted criteria and how each piece of evidence is counted, and the vendor transparency scoreboard shows where those same criteria have already been applied. For tirzepatide specifically, the working sequence is short: confirm identity by MS, confirm purity with a chromatogram, confirm quantity per vial against the labelled content, then confirm that the lot number, the date and the laboratory on the certificate match the vial in front of you.

This guide is educational and concerns laboratory documentation only. Research peptides are supplied for research use only. Nothing here is medical advice, and no information on use, administration or effects is provided or implied. A certificate of analysis describes composition, not safety.

Research & education only. PeptideTrust rates documentary transparency, not product quality or safety. Nothing here is medical advice or a recommendation to purchase or use any substance. Research peptides referenced are for laboratory use.

Frequently Asked Questions

Does a tirzepatide CoA prove the vial contains tirzepatide?
Only if it includes identity data. Mass spectrometry (MS or LC-MS) compares the observed molecular mass with the mass expected for the sequence claimed, which is what rules out a different compound. An HPLC purity figure on its own cannot do this, because chromatography separates a sample without identifying what the peaks are.
Is a purity figure of 99 percent enough if there is no chromatogram?
No. A percentage is a conclusion, and the chromatogram is the evidence that supports it, including the baseline, the retention time of the main peak and the areas of any impurity peaks. Without the trace and the method parameters, there is no way to check whether the figure follows from the data. A purity number with no chromatogram is a recognised transparency red flag.
Why might a vial contain less peptide than the label states?
Purity by HPLC is relative to total peak area, so it says nothing about the mass actually in the vial. Quantity is a separate measurement, made by an HPLC assay against a reference standard or by amino acid analysis for net peptide content, which also accounts for water, salts and counter-ions such as TFA or acetate. Underfilled vials are a known issue, so the quantification section should compare the measured value with the labelled content for that lot.
Should a tirzepatide CoA include endotoxin and sterility results?
A standard identity and purity CoA normally does not, and that absence is common rather than suspicious. Endotoxin testing by LAL assay falls under USP 85 and sterility testing under USP 71, and they are separate tests: passing one does not imply the other. If endotoxin or sterility testing is advertised, a lot-specific report naming the method, result, units and limit should be available; a silent certificate should never be read as a sterility guarantee.
See the full scoreboard → 35 vendors ranked by CoA transparency.

Related guides